期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 47, 期 4-5, 页码 938-942出版社
ELSEVIER
DOI: 10.1016/j.jpba.2008.02.027
关键词
iridium; atomic absorption spectrometry; bioorganometallic chemistry; cellular uptake
An electrothermal atomic absorption spectrometric method to quantify the iridium content of HT-29 colon carcinoma cells exposed to iridium metallodrugs was developed. Optimisation of the procedure involved the evaluation of pyrolysis and atomisation conditions (optimal values were 1400 degrees C for pyrolysis and 2400 degrees C for atomisation) and the addition of appropriate additives. The presence of cellular components as well as the addition of nitric acid and hydrochloric acid led to enhanced absorption signals and suggested the use of matrix matched calibration. The described method allows the measurement of iridium in cell suspensions in the low mu g/L range (linear dynamic range: 10-450 mu g/L.) with a detection limit of 11.2 mu g/L. The applicability of the method was tested by means of a novel iridium metallodrug. First results on the complex [IrCl3(DMSO)(phen)] indicated a low cellular uptake (21.2 mu M at incubation with 100 mu M) of this iridium species in HT-29 cells compared to other metal containing antitumor drugs. (c) 2008 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据